Assistant Clinical Professor, Medicine, Tufts Medical Center
Family Medicine
Dr. William P. Castelli, MD
|
|
Give Review
William Castelli practices Family Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification". William Castelli is a published doctor and has 101 publications published. The lastest was: 'Are risk factors for patellofemoral and tibiofemoral knee osteoarthritis different?' He accepts Medicare.
Publications
- William Peter Castelli, MD: a conversation with the editor [interview by William Clifford Roberts].
- Risk Factors in the Elderly: A View From Framingham.
- Cardiovascular Disease and lipoproteins: available evidence and remaining questions. Reactor panel and open forum.
- From phenotype to genotype.
- The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study.
- Lipoproteins and cardiovascular Disease: biological basis and epidemiological studies.
- Poor design invalidates meat study.
- Are risk factors for patellofemoral and tibiofemoral knee osteoarthritis different?
- Round table discussion: practical issues in the management of dyslipidaemic patients.
- [With hypertension under control, Dr. William Castelli now can attack Coronary disease. Interview by Robert Henry].
- Cholesterol reduction and life expectancy.
- Fat macroglobulinemia and fat embolism.
- Unlikely association between clinically apparent herpesvirus infection and Coronary incidence at older ages. The Framingham Heart Study.
- Celebrating 40 years of the Framingham Heart Study.
- Noninvasive cardiology tools and endpoints in genetic epidemiology: the Framingham Study.
- Effects of cigarette smoking on fasting triglyceride, total cholesterol, and HDL-cholesterol in women.
- The aging thyroid. The use of thyroid hormone in older persons.
- Profile of the Coronary-prone individual. Assessment of risk of developing Coronary heart disease. The Framingham study.
- Serum cholesterol, lipoproteins, and the risk of Coronary heart disease. The Framingham study.
- The natural history of congestive Heart failure: the Framingham study.
- Fat particles in plasma. The macroglobule: its relevance to the concept of fat embolism.
- Lipid studies for assessing the risk of cardiovascular Disease and hyperlipidemia.
- Heart failure and hypertension.
- Quantitation of beta lipoprotein (LDL) cholesterol by densitometric evaluation of disc electropherograms.
- Lipemia retinalis: microcirculatory changes and lipid studies in a family.
- Role of diabetes in congestive Heart failure: the Framingham study.
- Effect of growth hormone on plasma triglycerides in man.
- The Framingham study of Coronary disease in women.
- Vital capacity and congestive Heart failure. The Framingham study.
- Role of blood pressure in the development of congestive Heart failure. The Framingham study.
- Electrocardiographic left ventricular hypertrophy and risk of Coronary heart disease. The Framingham study.
- Heparin and human lipid metabolism.
- Weight and thirty-year mortality of men in the Framingham Study.
- The aging thyroid. Thyroid deficiency in the Framingham Study.
- Plasma lipoprotein levels in vegetarians. The effect of ingestion of fats from dairy products.
- Hyperuricemia as a risk factor of Coronary heart disease: The Framingham Study.
- A population at risk. Prevalence of high cholesterol levels in Hypertensive patients in the Framingham Study.
- Echocardiographically determined left ventricular structural and functional correlates of complex or frequent ventricular Arrhythmias on one-hour ambulatory electrocar...
- Considerations in the use of echocardiography in epidemiology. The Framingham Study.
- Incidence of Coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.
- The triglyceride issue: a view from Framingham.
- Gout and Coronary heart disease: the Framingham Study.
- Plasma cholesterol variation in the National Heart, Lung and Blood Institute Twin Study.
- High density lipoprotein cholesterol and mortality. The Framingham Heart Study.
- Silent Myocardial ischemia in asymptomatic survivors of unrecognized Myocardial infarction and matched controls.
- Type A behavior and mortality from Coronary disease in the Framingham study.
- Cholesterol and lipids in the risk of Coronary artery disease--the Framingham Heart Study.
- The association between cholesterol cholelithiasis and Coronary heart disease in Framingham, Massachusetts.
- [Framingham 36 years later].
- How to help patients cut down on saturated fat. A simple strategy.
- Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study.
- Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study.
- Risk of ventricular Arrhythmias in left ventricular hypertrophy: the Framingham Heart Study.
- Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study.
- The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study.
- Cardiovascular risk factors and graded treadmill exercise endurance in healthy adults: The Framingham Offspring Study.
- Leisure time physical activity in the Framingham Offspring Study. Description, seasonal variation, and risk factor correlates.
- Serum prolactin and aging: basal values and changes with estrogen use and hypothyroidism.
- Plasma lipoproteins in healthy octogenarians: lack of reduced high density lipoprotein cholesterol levels: results from the Framingham Heart Study.
- Is coffee consumption a contributor to cardiovascular Disease? Insights from the Framingham Study.
- Cardiovascular risk factors in the elderly.
- Left ventricular mass and incidence of Coronary heart disease in an elderly cohort. The Framingham Heart Study.
- The role of plasma lipids as predictors of risk for Coronary heart disease.
- High density lipoprotein cholesterol. A 16-year longitudinal study in aging male twins.
- Diet, smoking, and alcohol: influence on Coronary heart disease risk.
- [Cholesterol. The complex relation of an indispensable enemy. Interview by Robert Henry].
- Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.
- Stratifying the patient at risk from Coronary disease: new insights from the Framingham Heart Study.
- Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy.
- Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (the Framingham Study).
- Twelve-year incidence of Coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study.
- The NHLBI Twin Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a).
- Relation of alcohol intake to left ventricular mass: The Framingham Study.
- Triglycerides and serum cholesterol.
- Myocardial infarction and Coronary death among women: psychosocial predictors from a 20-year follow-up of women in the Framingham Study.
- Echocardiographic left ventricular hypertrophy: clinical characteristics. The Framingham Heart Study.
- Epidemiology of triglycerides: a view from Framingham.
- LDL particle size distribution. Results from the Framingham Offspring Study.
- Lipids and risk of Coronary heart disease. The Framingham Study.
- Concerning the possibility of a nut...
- The Framingham Offspring Study. Design and preliminary data.
- Mortality significance of hypercholesterolemia and hypertriglyceridemia.
- The omnicardiogram Study of a proposed method for detecting Coronary heart disease in an asymptomatic population.
- Genetics of plasma cholesterol and triglycerides: a study of adult male twins.
- Predicting Coronary heart disease in middle-aged and older persons. The Framington study.
- Blood pressure aggregation in families.
- A comparison of blood pressure, total cholesterol and cigarette smoking in parents in 1950 and their children in 1970.
- An investigation of Coronary heart disease in families. The Framingham offspring study.
- Obesity, lipids, and glucose intolerance. The Framingham Study.
- Exercise and high-density lipoproteins.
- How many drinks a day?
- The association of total cholesterol, triglycerides and plasma lipoprotein cholesterol levels in first degree relatives and spouse pairs.
- Oral contraceptive use and fasting triglyceride, plasma cholesterol and HDL cholesterol.
- Cholesterol in the prediction of atherosclerotic Disease. New perspectives based on the Framingham study.
- Cigarette smoking and HDL cholesterol: the Framingham offspring study.
- Diabetes, blood lipids, and the role of obesity in Coronary heart disease risk for women. The Framingham study.
- CHD risk factors in the elderly.
- High density lipoprotein as a protective factor against Coronary heart disease. The Framingham Study.
- Distribution of triglyceride and total, LDL and HDL cholesterol in several populations: a cooperative lipoprotein phenotyping study.
- HDL cholesterol and other lipids in Coronary heart disease. The cooperative lipoprotein phenotyping study.
Schools
Universite Catholique De Louvain Faculte De Medecine
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
- Family Medicine
Accepted Insurances
- Bakery & Confectionary Union Plan
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- CHAMPVA
- Great West Healthcare-Cigna PPO
- LocalPlus
- Commercial Insurance Company
- Fallon Community Health Plan
- Harvard Pilgrim Health Care PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Neighborhood Health Plan
- Network Health
- Tufts Health Plans
- Tufts PPO
- UniCare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
SUNY Health Science Center at Brooklyn -
Catholic University of Leuven
Hospital
-
MetroWest Medical Center
Drug Facts
| NPI NUMBER | 1427011279 | |
| NPPES Provider LastName | CASTELLI | |
| NPPES Provider FirstName | WILLIAM | |
| NPPES Provider ZIPCode | 017026358 | |
| NPPES Provider State | MA | |
| Specialty Description | Preventive Medicine | |
| Total Claim Count | 604.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427011279 |
| Last Name Of The Provider | CASTELLI |
| First Name Of The Provider | WILLIAM |
| View All |
Similar Doctors
|
|
Dr. Elizabeth K. Ascher, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard A. Sussman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. George P. Kinzfogl III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Z. Young, MD |
|
|
Dr. Christopher A. Gange, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lama Almulki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neli Azimi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alfred G. Shina, MD |
|
|
Dr. Usha S. Rallapalli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick H. Guadiz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sanjeev Sharma, MD
This Doctor is OpenDoctor Recommended.
|